Reactive perforating collagenosis treated with dupilumab: A case report and literature review [0.03%]
度普利尤单抗治疗反应性穿刺性胶原病1例及相关文献复习
Lan Guo,Yue-Ping Zeng,Hong-Zhong Jin
Lan Guo
Comparative study between topical application of triamcinolone acetonide after fractional carbon dioxide laser versus microneedling in the treatment of resistant alopecia areata [0.03%]
治疗雄激素性秃发抵抗者的点阵二氧化碳激光与微针疗法后外用曲安奈德的比较研究
Mai Mohamed Omar,Zakaria Mahran Obaid,Osama Magdy Elshahat Sayedahmed
Mai Mohamed Omar
Alopecia areata (AA) is a disease that affects the psychological well-being of the affected individuals. Laser-assisted drug delivery and microneedling (MN) are promising methods for the treatment of different dermatological diseases. The a...
Randomized Controlled Trial
Dermatologic therapy. 2022 Dec;35(12):e15913. DOI:10.1111/dth.15913 2022
Miriam Fernández-Parrado,Jorge Arostegui-Aguilar,Héctor Perandones-González et al.
Miriam Fernández-Parrado et al.
Gradually increasing the dosing interval of Secukinumab for moderate to severe plaque psoriasis: A single-center, uncontrolled, prospective study in 36 weeks [0.03%]
塞库辛单抗治疗中重度斑块状银屑病患者的研究：一项为期54周的单中心、非盲、观察性研究
Xi-Bei Chen,Yu-Xin Zheng,Li-Ran Ye et al.
Xi-Bei Chen et al.
Secukinumab is a recombinant, fully human monoclonal anti-IL-17A antibody approved to treat moderate-to-severe psoriasis and psoriatic arthritis. Its effectiveness and safety have been confirmed, but a gradual increase in the secukinumab do...
Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech) [0.03%]
接种新冠疫苗(辉瑞-BNT)第一剂后出现甜综合征病例报告
Min Jae Kim,Jee Woo Kim,Jung-Im Na
Min Jae Kim
Joanna Chojnacka-Purpurowicz,Ewa Wygonowska,Waldemar Placek et al.
Joanna Chojnacka-Purpurowicz et al.
Drug-induced gingival overgrowth (DIGO) is an undesirable effect resulting from the therapy of one of the three groups of drugs: phenytoin, calcium channel blockers, and cyclosporine A (CsA). It is caused by a fibrous overgrowth leading to ...
Lihua Ye,Zhenfei Wu,Changrong Li et al.
Lihua Ye et al.
Ustekinumab (brand name Stelara®) is a human interleukin-12 and -23 antagonist and has been indicated for the treatments of moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This review aims ...
Real-world evidence of biological agents in dermatology: A review of its applications, advantages, and limitations [0.03%]
皮肤病学中生物制剂真实世界证据的回顾性研究：应用、优势和局限性
Jiaqing Shen,Yi Liu
Jiaqing Shen
Randomized controlled trials (RCTs) are regarded as the gold standard of evidence-based medicine. However, the disadvantages of RCTs have been well-documented for a lengthy period of time. Due to the carefully controlled conditions, a small...
Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies [0.03%]
激光、滴眼液噻吗洛尔及联合疗法治疗婴幼儿血管瘤疗效和安全性的meta分析
Huaxu Huang,Xuanfeng Chen,Beichen Cai et al.
Huaxu Huang et al.
Topical timolol and lasers are widely used for the treatment of infantile hemangioma (IH), and they can replace propranolol as the first-line treatment of IH. We aimed to investigate the efficacy and safety of topical timolol alone or laser...
Julia Föhr,Martin Gschnell,Tomas Cunha et al.
Julia Föhr et al.